OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoadjuvant or Perioperative Approach in Lung Cancer
Marina Chiara Garassino, Valter Torri
New England Journal of Medicine (2024) Vol. 390, Iss. 19, pp. 1816-1818
Closed Access | Times Cited: 7

Showing 7 citing articles:

Exploring Inflammatory Parameters in Lung Cancer Patients: A Retrospective Analysis
Cătălin Vlăduț Ionuț Feier, Călin Muntean, Alaviana Monique Faur, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 552-552
Open Access | Times Cited: 7

Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer
Wara Naeem, Arsalan Khan, Oluwamuyiwa W. Adebayo, et al.
Annals of Surgical Oncology (2025)
Closed Access

Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial
Mattia Boeri, Federica Sabia, Roberta Eufrasia Ledda, et al.
The Lancet Regional Health - Europe (2024) Vol. 46, pp. 101070-101070
Open Access | Times Cited: 2

Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Jonathan Spicer, Mariano Provencio
New England Journal of Medicine (2024) Vol. 391, Iss. 6, pp. 572-574
Closed Access | Times Cited: 1

Traitement péri-opératoire avec pembrolizumab et chimiothérapie néoadjuvante pour les CBNPC
Tom Bastin, Quentin Dominique Thomas
Bulletin du Cancer (2024) Vol. 111, Iss. 11, pp. 1000-1002
Closed Access | Times Cited: 1

Perioperative PD-1/PD-L1 inhibitors for resectable non-small cell lung cancer: A meta-analysis based on randomized controlled trials
Hai Huang, Lianyun Li, Ling Tong, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0310808-e0310808
Open Access | Times Cited: 1

NSCLC-Immuntherapie – neoadjuvant oder perioperativ?
Alexander Kretzschmar
Onkologische Welt (2024) Vol. 15, Iss. 04, pp. 203-203
Closed Access

Page 1

Scroll to top